Ravi A. Madan
- Oncology top 0.5%
- Immunology top 0.5%
- Pulmonary and Respiratory Medicine top 1%
- Molecular Biology top 5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Co-authors
- James L. GulleyJeffrey SchlomWilliam L. DahutPhilip M. ArlenChristopher R. HeeryMarijo BilušićRenee N. DonahueSeth M. Steinberg
- Topics
- Prostate Cancer Treatment and Research (154 papers)Cancer Immunotherapy and Biomarkers (135 papers)Immunotherapy and Immune Responses (124 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesGermanySpain
In The Last Decade
Ravi A. Madan
275 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Oncology 4.3k
- Immunology 3.2k
- Pulmonary and Respiratory Medicine 2.2k
- Molecular Biology 1.5k
- Radiology, Nuclear Medicine and Imaging 704
Countries citing papers authored by Ravi A. Madan
This map shows the geographic impact of Ravi A. Madan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi A. Madan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi A. Madan more than expected).
Fields of papers citing papers by Ravi A. Madan
This network shows the impact of papers produced by Ravi A. Madan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi A. Madan. The network helps show where Ravi A. Madan may publish in the future.
Co-authorship network of co-authors of Ravi A. Madan
This figure shows the co-authorship network connecting the top 25 collaborators of Ravi A. Madan. A scholar is included among the top collaborators of Ravi A. Madan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi A. Madan. Ravi A. Madan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 8 | |
| 3 | 9 | |
| 4 | 7 | |
| 5 | 84 | |
| 6 | 9 | |
| 7 | 43 | |
| 8 | 9 | |
| 9 | 45 | |
| 10 | 58 | |
| 11 | 116 | |
| 12 | Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumorsbreakdown → | 327 |
| 13 | 51 | |
| 14 | 3 | |
| 15 | 26 | |
| 16 | 104 | |
| 17 | 101 | |
| 18 | 101 | |
| 19 | 201 | |
| 20 | 119 |
About Ravi A. Madan
Ravi A. Madan is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 286 papers that have together received 6.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (154 papers), Cancer Immunotherapy and Biomarkers (135 papers) and Immunotherapy and Immune Responses (124 papers). The work is most often cited by research in Oncology (4.3k citations), Immunology (3.2k citations) and Pulmonary and Respiratory Medicine (2.2k citations). Ravi A. Madan has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include James L. Gulley, Jeffrey Schlom, William L. Dahut, Philip M. Arlen, Christopher R. Heery, Marijo Bilušić, Renee N. Donahue, Seth M. Steinberg, Jennifer L. Marté and Caroline Jochéms. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.